📰 Beta Lactam News
Beta Lactam News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beta Lactam. Real-time updates on events, politics, business and more.
February 24, 2024
The good news is that the U.S. FDA’s complete response letter (CRL) for Venatorx Pharmaceuticals Inc.’s intravenous antibiotic combination, cefepime-taniborbactam, in complicated urinary tract infections (cUTIs) requested no additional clinical testing. The bad news is the inevitable delay for a drug Venatorx and partner Melinta Therapeutics Inc. are aiming to position as a much-needed option for the fight against drug-resistant gram-negative infections.
November 18, 2023
NEW YORK, Nov. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...
March 27, 2023
(This story has not been edited by THE WEEK and is auto-generated from a PTI
March 27, 2023
Ahmedabad (Gujarat) [India], March 27 (ANI/PNN): Ahmedabad based Sotac Pharmaceuticals Ltd
January 30, 2023
/PRNewswire/ -- Allied Market Research published a report, titled, "Middle East Blood Plasma Derivatives Market by Type (Albumin, Factor VII, Factor IX...
January 25, 2023
"Topical Antibiotics Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments,
January 25, 2023
Data Bridge Market Research analyses a growth rate in the global topical antibiotics market in the forecast period 2022-2029. The expected CAGR of global...
December 21, 2022
Cancer has a major impact on society in the United States and worldwide. Cancer statistics describe what happens in large groups of people and provide a...
December 16, 2022
Data Bridge Market Research has recently published a Report, titled, "Lipids Market" The report offers an extensive analysis of key growth strategies, drivers,
November 2, 2022
Urinary Tract Infection Treatment Market for Penicillin and Combination Drugs Segment to Grow at Highest CAGR during 2020–2027